December 19, 2017 / 1:13 PM / 6 months ago

BRIEF-Biofrontera Files Investigational New Drug Application

Dec 19 (Reuters) - BIOFRONTERA AG:

* PTA-NEWS: BIOFRONTERA AG: BIOFRONTERA FILES INVESTIGATIONAL NEW DRUG APPLICATION

* BIOFRONTERA - ‍FILES INVESTIGATIONAL NEW DRUG APPLICATION WITH U.S. FDA FOR PHASE III TRIAL OF AMELUZ TO TREAT BASAL CELL CARCINOMA​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below